Molecular diagnosis of infection
- Laboratory diagnosis
Molecular tests find a microbe's genes directly in the sample, often in hours and without waiting for culture.
What it is
Nucleic acid amplification tests (NAATs) copy a short stretch of a microbe's DNA or RNA millions of times until it can be detected. They are highly sensitive and fast, work for organisms that are hard or slow to culture, and can also spot resistance genes. Sequencing goes further: it reads whole genes or genomes to identify rare organisms and to link cases in an outbreak.
Key facts
- A lower cycle threshold (Ct) means more target in the sample; Ct values are not comparable between different tests.
- A positive NAAT shows that genetic material is present, not that the organism is alive or causing disease (for example, C. difficile carriage or lingering SARS-CoV-2 RNA).
- Resistance genes can be detected directly: mecA (MRSA), vanA or vanB (vancomycin-resistant enterococci) and carbapenemase genes (KPC, NDM, OXA-48-like); absence of a gene does not prove susceptibility.
- Whole-genome sequencing has replaced older DNA fingerprinting for foodborne outbreak surveillance; cases whose isolates are nearly identical are likely linked.
- Culture-independent tests leave no isolate, so labs may still culture positive samples for susceptibility testing and public-health typing.
- Pathogen genomic surveillance compares the genomes of isolates across places and time: it flags new variants (as with SARS-CoV-2), traces chains of transmission in hospitals and communities, and tells tuberculosis relapse from reinfection.
- Genomes can predict resistance: the WHO catalogue of M. tuberculosis mutations interprets sequencing results for 13 anti-tuberculosis drugs; prediction is most accurate for rifampicin and isoniazid and weakest for pyrazinamide.
- Resistance genes found in hospital isolates can reveal spread between patients early and prompt stronger infection control; sequencing of wastewater extends surveillance to resistance genes, typhoid, cholera and polio.
Step by step
- The sample is treated to break microbes open and extract their DNA or RNA; RNA is first copied into DNA (reverse transcription).
- Primers that match a short stretch unique to the target bind only if that microbe's genes are present.
- Each heating and cooling cycle roughly doubles the copies of that stretch.
- A fluorescent probe glows more as copies build up, and the instrument reads the signal every cycle.
- The cycle at which the signal crosses the threshold is the Ct: the more target at the start, the lower the Ct.
- No signal by the last cycle means the target was not detected, within the limits of that test.
Main molecular methods
| Method | How it works | Strength | Limitation |
|---|---|---|---|
| Real-time PCR (and RT-PCR for RNA) | Amplifies a target and reads fluorescence each cycle | Fast, sensitive, quantitative (viral load) | One or a few targets; also detects dead organisms or leftover nucleic acid |
| Isothermal amplification | Amplifies at a single temperature | Simple equipment; suits point-of-care use | Fewer targets; quality varies by test |
| Syndromic multiplex PCR panels | Many targets from one sample (respiratory, stool, CSF, positive blood culture) | Broad answer in hours | Costly; detects colonizers and old infections; few resistance genes; no isolate for full testing |
| Automated real-time PCR for MTB/RIF | Detects Mycobacterium tuberculosis and rpoB mutations | Tuberculosis and rifampicin resistance in hours | Other drugs need further testing; DNA persists after cure |
| Targeted gene sequencing (16S, ITS) | Reads a conserved gene and compares with databases | Identifies rare or culture-negative organisms | Mixed samples are hard to read |
| Whole-genome sequencing | Reads the entire genome of an isolate | Outbreak typing, resistance and virulence genes | Needs bioinformatics and time |
| Metagenomic sequencing | Reads all nucleic acid in the sample | Unbiased search for any pathogen | Expensive, background contamination, limited availability |
Clinical notes
- Chlamydia and gonorrhoea: NAAT on first-void urine or a vaginal swab is the test of choice.
- HIV, hepatitis B and hepatitis C: quantitative viral load guides and monitors treatment.
- C. difficile: test only unformed stool from patients with diarrhoea, because colonization is common.
- Positive blood culture panels can name the organism and key resistance genes hours before conventional identification.
Common traps
- A positive PCR proves active infection: it detects nucleic acid, which persists after cure (tuberculosis, SARS-CoV-2) or comes from carriers (C. difficile).
- No resistance gene detected means the organism is susceptible: panels test few genes and other mechanisms exist, so phenotypic testing on an isolate is still needed.
- The same Ct means the same amount of virus on any test: Ct values are not comparable between different tests.
- Molecular tests make culture unnecessary: they leave no isolate, so culture is still needed for full susceptibility testing and public-health typing.
- Every organism a multiplex panel detects is causing the illness: panels also detect colonizers and old infections, so clinical context decides.
Test yourself
Think of the answer, then tap the question to see it.
A patient treated for tuberculosis last year has a positive molecular test on sputum again. Does this alone prove relapse?
No. DNA can persist after cure. Culture and the clinical picture are needed to show live, replicating bacilli.
Stool from a patient without diarrhoea is PCR-positive for toxigenic C. difficile. What is the most likely meaning?
Colonization, not infection. Carriage is common, which is why only unformed stool from patients with diarrhoea should be tested.
A positive blood culture panel detects S. aureus and no mecA gene. What is still needed, and why?
Full susceptibility testing on the isolate: the absence of mecA predicts methicillin susceptibility, but the panel does not cover other mechanisms or other drugs.
A molecular test finds M. tuberculosis with an rpoB mutation. What does this imply, and what comes next?
Rifampicin resistance, a marker of possible multidrug-resistant tuberculosis; testing for the other drugs follows at a reference laboratory.
Why is whole-genome sequencing used to link cases in a foodborne outbreak?
It reads each isolate's entire genome; cases whose isolates are nearly identical are likely from the same source, with finer resolution than older DNA fingerprinting.
Connections
Microorganisms11
In Pharmacology1
Educational content on microorganisms; not a treatment guide and no substitute for a health professional's advice. No doses are given.
Sources: Respiratory Pathogens Panel (MedlinePlus (NLM), 2025); About Whole Genome Sequencing (CDC (PulseNet), 2024); Fecal culture (MedlinePlus (NLM), 2025); Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance, 2nd ed (World Health Organization (WHO), 2023); Global genomic surveillance strategy for pathogens with pandemic and epidemic potential, 2022–2032 (World Health Organization (WHO), 2022); Advancing pathogen genomics in resource-limited settings (Cell Genomics (Europe PMC), 2023); Algorithmic Determinants of Performance Heterogeneity in Whole-Genome Sequencing-Based Prediction of Drug Resistance in Mycobacterium tuberculosis: A Systematic Review and Meta-Analysis (Microorganisms (Europe PMC), 2026).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
